Ocuphire Pharma reduces stockholder meeting quorum requirement from majority to one-third

Opus Genetics, Inc.

Board approved amendment to Bylaws reducing quorum for stockholder meetings from a majority to one-third of voting power, effective June 1, 2023.
Amendment modifies Section 8 of Article III of the Second Amended and Restated Bylaws.
No changes to fiscal year or other provisions of the Bylaws.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Opus Genetics, Inc.: Reduced stockholder meeting quorum from a majority to one-third of voting power (effective 2023-06-01).

Change: bylaw amendment
Effective: 2023-06-01

Exact text from the filing

The Bylaws Amendment amended Section 8 of ARTICLE III of the Bylaws to reduce the quorum requirement for all meetings of stockholders of the Company from a majority of the voting power of the outstanding shares of stock entitled to vote to one-third of the voting power of the outstanding shares of stock entitled to vote.

View on SEC.gov

55 governance changes filed in the last 30 days. Browse all governance changes →

Opus Genetics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-028066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.